DBV Technologies (DBVT) Soars 80% on Validation of Viaskin Peanut Application from EMA
DBV’s Viaskin™ Peanut (DBV712) is currently being tested through various stages for the treatment of children suffering from peanut allergies. Shares of DBV Technologies (DBVT)